secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2026-07-09T20:30:35+00:00
Accession:  0001493152-26-032694
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics prices $3.0M private placement with up to $6.0M in warrant proceeds
--------------------------------------------------------------------------------

- Gross proceeds of ~$3.0M from sale of 2,112,677 pre-funded warrants and Series F/G warrants at $1.419 per unit.
- Potential additional ~$6.0M if Series F (5-year) and Series G (18-month) warrants fully exercised at $1.42/share.
- Net proceeds ~$2.7M after fees; intended for clinical trials, patent portfolio, and working capital.
- H.C. Wainwright acted as exclusive placement agent; received 7.0% cash fee and 126,761 placement agent warrants.
- Company to seek stockholder approval for warrant issuance; resale registration statement to be filed within 15 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315226032694/0001493152-26-032694-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315226032694/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-032694

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer